This NDC is on FDA's drug shortage list (posted Oct 12, 2022)

Product Information

DEXTROAMP-AMPHETAM 12.5 MG TAB is a generic product labeled by Elite Laboratories, Inc., priced at $0.3718 per EA under NDC 64850050301. Its NADAC has been published 181 times since Jun 7, 2023.

FDA first approved this application on Dec 7, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DEA Schedule CII

Strength

3.125; 3.125; 3.125; 3.125 mg/1; mg/1; mg/1; mg/1

NDC

64850050301

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA211352

FDA Approved

12/7/2018

TE Code

AB

On Market Since

12/29/2022

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price Statistics

The NADAC for DEXTROAMP-AMPHETAM 12.5 MG TAB has been published 181 times since Jun 7, 2023, and over the history we have for it it has declined 39.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3718 per EA
All-time high$0.6346 (Jul 12, 2023)
All-time low$0.2862 (Nov 20, 2024)
52-week high$0.3718
52-week low$0.3065
Median price$0.3762
Average price$0.4118
Largest weekly change-45.1% (Nov 20, 2024)
Weeks tracked181
Tracking sinceJun 7, 2023

Price History

1W

+6.0%

1M

+3.5%

3M

+7.9%

6M

+21.3%

1Y

+7.0%

3Y

-28.8%

5Y

N/A

All

-39.5%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DEXTROAMP-AMPHETAM 12.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAM 12.5 MG TAB, manufactured by Elite Laboratories, Inc., is $0.3718 per EA (NDC 64850050301), effective Nov 18, 2026.

How has the price of DEXTROAMP-AMPHETAM 12.5 MG TAB changed over time?

Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAM 12.5 MG TAB has declined 39.5%. It has been tracked across 181 weekly CMS publications since Jun 7, 2023.

What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAM 12.5 MG TAB?

Since Jun 7, 2023, the NADAC for DEXTROAMP-AMPHETAM 12.5 MG TAB has ranged from a low of $0.2862 (Nov 20, 2024) to a high of $0.6346 (Jul 12, 2023), with a median of $0.3762 per EA.

Are there cheaper alternatives to DEXTROAMP-AMPHETAM 12.5 MG TAB?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DEXTROAMP-AMPHETAM 12.5 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures DEXTROAMP-AMPHETAM 12.5 MG TAB?

DEXTROAMP-AMPHETAM 12.5 MG TAB (NDC 64850050301) is labeled by Elite Laboratories, Inc., and CMS classifies it as a generic product.

Is DEXTROAMP-AMPHETAM 12.5 MG TAB in shortage?

Yes — NDC 64850050301 is currently listed in FDA's drug shortage database (posted Oct 12, 2022).